Signal active
Investment Firm
Overview
Tandem diabetes care provides products that empower both people with diabetes and those who care for them. It offers diabetic insulin pumps for adults and children to diabetes needs, including keeping blood glucose levels within target ranges.
Highlights
2006
Biotechnology
1001-5000
2
1
1
Late Stage Venture
N/A
Location
San Diego, California, United States, North America
Contact Information
Social
Profile Resume
Tandem Diabetes Care, established in 2006 and headquartered in United States, North America., specializes in Late Stage Venture investments across Health Care, Medical, Medical Device, Information Technology, Venture Capital, Life Science, Financial Services, Finance, Asset Management, Business Development. The organization boasts a portfolio of 2 investments, with an average round size of $61.6M and 1 successful exits. Their recent investments include CeQur Simplicity, VI Partners, Schroders, Endeavour Vision, Credit Suisse Entrepreneur Capital. The highest investment round they participated in was $13.4B. Among their most notable exits are CeQur Simplicity and VI Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
2
0
1
1
Investments
2
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Apr 13, 2021 | CeQur Simplicity | Health Care | 115.0M |
Sep 01, 2022 | - | - | 8.2M |
Exits
1
Funding Timeline
2
7
0
Funding Rounds
2
Tandem Diabetes Care has raised 2 rounds. Their latest funding was raised on Sep 01, 2022 from a Corporate Round - AMF Medical round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Apr 13, 2021 | Series C - CeQur Simplicity | - | 115.0M | - |
Sep 01, 2022 | Corporate Round - AMF Medical | - | 8.2M | - |
Investors
17
Tandem Diabetes Care is funded by 17 investor(s). CRG and Delphi Ventures Kantor are the most recent investors.
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
- | No | Post-IPO Equity - Tandem Diabetes Care | 23.1M |
- | No | Post-IPO Equity - Tandem Diabetes Care | 69.0M |
- | No | Post-IPO Equity - Tandem Diabetes Care | 115.0M |
- | No | Post-IPO Debt - Tandem Diabetes Care | 275.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
News
Aug 26, 2024
Business Wire - Tandem Diabetes Care Announces Upcoming Conference Participation
News
Jul 30, 2024
Business Wire - Tandem Diabetes Care Announces Upcoming Conference Presentation
News
Jun 24, 2024
Business Wire - Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer
News
Jun 20, 2024
Medical Product Outsourcing - Tandem Diabetes Names Jean-Claude Kyrillos as COO
News
Jun 18, 2024
thefly.com - Tandem Diabetes extends development agreement with DexCom
News
Jun 17, 2024
San Diego Business Journal - Tandem Diabetes Shares Riding High